Moderna announces promising results from next-generation Covid vaccine trials

Moderna’s next generation Covid-19 jab could mean that people will only need one annual booster, the pharmaceutical firm has said as it released promising results from trials of its bivalent vaccine, which targets both the original Covid strain and the Omicron variant.